Neil Brewis (F-Star Biotechnology Ltd. (F-Star Therapeutics))

Brewis, Neil (F-Star 201611 CSO)

	Organisation	F-Star Biotechnology Ltd. (F-Star Therapeutics)
	Group	Sino Biopharm (Group)
	Product	mAb2 bispecific antibody platform
	Product 2	mAB² antibody (mAb-square)

Record changed: 2021-10-22

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Neil Brewis

[1] F-Star Therapeutics Ltd.. (10/20/21). "Press Release: F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics". Cambridge & Cambridge, MA....
[2] F-Star Biotechnology Ltd.. (3/25/19). "Press Release: F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]